SCHEMBL17779274

SCHEMBL17779274

COc1ccccc1NS(=O)(=O)c1cc(N)ccc1N1CCOCC1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.80
ALDH1A1 P00352 12/20 0.80
KDM4E B2RXH2 4/20 0.80
MEN1 O00255 3/20 0.80
KMT2A Q03164 3/20 0.80
GAA P10253 1/20 0.80
APOBEC3G Q9HC16 1/20 0.80
HTT P42858 6/20 0.66
LMNA P02545 5/20 0.66
L3MBTL1 Q9Y468 3/20 0.65
NPSR1 Q6W5P4 2/20 0.65
POLB P06746 4/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
HPGD P15428 2/20 0.60
GPR55 Q9Y2T6 2/20 0.60
DUSP3 P51452 1/20 0.60
PTPN5 P54829 1/20 0.60
PTPN11 Q06124 1/20 0.60
PKM P14618 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774639 0.90 MAPT (0.98) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL19788672 0.89 MAPT (1.00) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17774618 0.86 MAPT (0.65) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17774670 0.84 MAPT (0.79) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17774603 0.81 KMT2A (0.68) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17779216 0.77 MAPT (0.61) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17779217 0.75 MAPT (0.59) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL17774604 0.74 MAPT (0.78) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL17774637 0.74 MAPT (0.75) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL15652359 0.74 MAPT (0.58) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION KRT18, ARSA, SQOR MAPT 2197/4885ALDH1A1 440/4885KDM4E 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.